BE650919A - - Google Patents

Info

Publication number: BE650919A
Authority: BE; Belgium

Application number

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1963-07-24

Filing date

1964-07-23

Publication date

1964-11-16

1964-07-23 Application filed filed Critical

1964-11-16 Publication of BE650919A publication Critical patent/BE650919A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/29—Saturated compounds containing keto groups bound to rings
- C07C49/313—Saturated compounds containing keto groups bound to rings polycyclic
- C07C49/323—Saturated compounds containing keto groups bound to rings polycyclic having keto groups bound to condensed ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BE650919D 1963-07-24 1964-07-23 BE650919A (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US29723363A	1963-07-24	1963-07-24
US376259A US3352912A (en)	1963-07-24	1964-06-18	Adamantanes and tricyclo[4. 3. 1. 1 3.8] undecanes

Publications (1)

Publication Number	Publication Date
BE650919A true BE650919A (fr)	1964-11-16

Family

ID=26970055

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE650919D BE650919A (fr)	1963-07-24	1964-07-23

Country Status (14)

Country	Link
US (1)	US3352912A (fr)
AT (1)	AT279581B (fr)
BE (1)	BE650919A (fr)
BR (1)	BR6460975D0 (fr)
CH (2)	CH476673A (fr)
DE (3)	DE1792295B1 (fr)
DK (3)	DK112027B (fr)
ES (1)	ES302369A1 (fr)
FI (3)	FI42322B (fr)
FR (1)	FR1572956A (fr)
GB (1)	GB1069563A (fr)
IL (1)	IL21753A (fr)
NL (2)	NL6408505A (fr)
SE (3)	SE330693B (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1294371B (de) *	1966-12-21	1969-05-08	Penicillin Ges Dauelsberg & Co	Verfahren zur Herstellung von 1-Aminoadamantan und dessen N-Alkyl- bzw. N-Cyclohexylderivaten
FR2034451A1 (fr) *	1969-01-02	1970-12-11	Philips Nv
DE1668571A1 (de) *	1967-01-23	1971-04-15	Du Pont	Herstellung von 2-Methylpolycyclomethylaminen
WO2003041707A1 (fr) *	2001-11-16	2003-05-22	Astrazeneca Ab	Derives de n-adamantylmethyle et intermediaires utilises dans des compositions pharmaceutiques et leurs procedes de preparation
US6949539B2 (en)	2000-06-07	2005-09-27	Astrazeneca Ab	Admantane derivatives
US7227038B2 (en)	2003-02-21	2007-06-05	Astrazeneca Ab	Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them
US7408065B2 (en)	2003-06-02	2008-08-05	Astrazeneca Ab	P2X7 receptor antagonists and their use
US7964616B2 (en)	2007-03-22	2011-06-21	Astrazeneca Ab	Compounds 679
US8106073B2 (en)	2007-11-30	2012-01-31	Astrazeneca Ab	Quinoline derivatives 057

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3449422A (en) *	1966-02-09	1969-06-10	Smithkline Corp	Pentacycloundecane amines
US3682922A (en) *	1969-01-16	1972-08-08	Searle & Co	N-acyl-n-{8 (n{40 ,n{40 -disubstituted amino)-alkyl{9 -1-adamantylmethylamines
JPS4828903B1 (fr) *	1969-07-19	1973-09-05
US3624086A (en) *	1969-11-10	1971-11-30	Searle & Co	Adamantanecarboxamidoalkanoic acid amides
US3852339A (en) *	1970-06-15	1974-12-03	Squibb & Sons Inc	Aminoalkoxyphenylurea derivatives
US3879400A (en) *	1973-11-16	1975-04-22	Upjohn Co	1-Lower alkyl-(1-adamantylmethyl)piperidines and process for their preparation
JPS5346950A (en) *	1976-10-12	1978-04-27	Kao Corp	(54)1-acetylaminotricyclo(4,3,1,12,5)undecane and its preparation
US4351847A (en) *	1981-06-26	1982-09-28	Pennwalt Corporation	Antiviral alpha, alpha-dialkyl adamantylethylamines
US4551552A (en) *	1984-05-23	1985-11-05	E. I. Du Pont De Nemours And Company	Process for preparing rimantadine
US4751245A (en) *	1986-06-25	1988-06-14	E. R. Squibb & Sons, Inc.	Antifungal derivatives of N-(6,6-dimethyl-2-hepten-4-ynyl)-1-naphthalenemethanamine and method of using same
US5576355A (en) *	1993-06-04	1996-11-19	Mobil Oil Corp.	Diamondoid derivatives for pharmaceutical use
US5684024A (en) *	1996-01-25	1997-11-04	Viropharma Incorporated	Pyrazole dimers compositions and methods for treating influenza
US5821243A (en) *	1996-07-22	1998-10-13	Viropharma Incorporated	Compounds compositions and methods for treating influenza
ES2175614T3 (es) *	1997-04-10	2002-11-16	Pfizer	Derivados fluorosustituidos de adamantano.
WO2003004461A1 (fr) *	2001-07-02	2003-01-16	Schering Corporation	Medicaments destines au traitement d'infections virales
CA2477088A1 (fr)	2002-02-22	2003-10-02	New River Pharmaceuticals Inc.	Systemes de distribution d'agents actifs et methodes de protection et d'administration d'agents actifs
WO2004056744A1 (fr) *	2002-12-23	2004-07-08	Janssen Pharmaceutica N.V.	Adamantyl acetamides utilises comme inhibiteurs de la hydroxysteroide deshydrogenase
BRPI0611966B1 (pt) *	2005-06-17	2022-05-03	Apogee Biotechnology Corporation	Composto ou sal farmaceuticamente aceitável do mesmo e composição farmacêutica os compreendendo
AR057623A1 (es)	2005-11-28	2007-12-05	Omega Bio Pharma H K Ltd	Materiales y metodos para el tratamiento de las infecciones virales
EP2912047B1 (fr)	2012-10-29	2016-08-24	Cipla Limited	Analogues de phosphonate antiviraux et leur procédé de préparation
JP6434980B2 (ja) *	2013-12-09	2018-12-05	ユニリーバー・ナームローゼ・ベンノートシヤープ	アダマンタンアミド製造方法
US10583171B2 (en)	2015-11-30	2020-03-10	INSERM (Institut National de la Santé et de la Recherche Médicale)	NMDAR antagonists for the treatment of diseases associated with angiogenesis
US11548893B2 (en)	2017-07-15	2023-01-10	Arisan Therapeutics Inc.	Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection

1964
- 1964-06-18 US US376259A patent/US3352912A/en not_active Expired - Lifetime
- 1964-07-18 DE DE19641792295 patent/DE1792295B1/de not_active Withdrawn
- 1964-07-18 DE DE19641793207 patent/DE1793207A1/de active Pending
- 1964-07-18 DE DE19641793208 patent/DE1793208A1/de active Pending
- 1964-07-20 CH CH946964A patent/CH476673A/de not_active IP Right Cessation
- 1964-07-20 BR BR160975/64A patent/BR6460975D0/pt unknown
- 1964-07-20 CH CH1457468A patent/CH479535A/de not_active IP Right Cessation
- 1964-07-23 SE SE09751/67A patent/SE330693B/xx unknown
- 1964-07-23 DK DK367964AA patent/DK112027B/da unknown
- 1964-07-23 SE SE8987/64A patent/SE321924B/xx unknown
- 1964-07-23 BE BE650919D patent/BE650919A/xx unknown
- 1964-07-23 SE SE9752/67A patent/SE320363B/xx unknown
- 1964-07-23 FI FI1584/64A patent/FI42322B/fi active
- 1964-07-23 ES ES0302369A patent/ES302369A1/es not_active Expired
- 1964-07-23 IL IL21753A patent/IL21753A/xx unknown
- 1964-07-24 NL NL6408505A patent/NL6408505A/xx unknown
- 1964-07-24 FR FR1572956D patent/FR1572956A/fr not_active Expired
- 1964-08-04 GB GB30940/64A patent/GB1069563A/en not_active Expired
- 1964-08-07 AT AT06819/68A patent/AT279581B/de not_active IP Right Cessation
1965
- 1965-07-09 DK DK353365AA patent/DK114199B/da unknown
- 1965-07-09 DK DK353265AA patent/DK114769B/da unknown
1969
- 1969-01-22 FI FI0197/69A patent/FI42548B/fi active
- 1969-01-22 FI FI0198/69A patent/FI42211B/fi active
1971
- 1971-02-17 NL NL7102097A patent/NL7102097A/xx unknown

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1294371B (de) *	1966-12-21	1969-05-08	Penicillin Ges Dauelsberg & Co	Verfahren zur Herstellung von 1-Aminoadamantan und dessen N-Alkyl- bzw. N-Cyclohexylderivaten
DE1668571A1 (de) *	1967-01-23	1971-04-15	Du Pont	Herstellung von 2-Methylpolycyclomethylaminen
FR2034451A1 (fr) *	1969-01-02	1970-12-11	Philips Nv
US6949539B2 (en)	2000-06-07	2005-09-27	Astrazeneca Ab	Admantane derivatives
WO2003041707A1 (fr) *	2001-11-16	2003-05-22	Astrazeneca Ab	Derives de n-adamantylmethyle et intermediaires utilises dans des compositions pharmaceutiques et leurs procedes de preparation
US7129246B2 (en)	2001-11-16	2006-10-31	Astrazeneca Ab	N-adamantlmethyl derivatives and intermediates as pharmaceutical compositions and processes for their preparation
AU2002347741B2 (en) *	2001-11-16	2008-03-13	Astrazeneca Ab	N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
US7227038B2 (en)	2003-02-21	2007-06-05	Astrazeneca Ab	Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them
US7408065B2 (en)	2003-06-02	2008-08-05	Astrazeneca Ab	P2X7 receptor antagonists and their use
US7964616B2 (en)	2007-03-22	2011-06-21	Astrazeneca Ab	Compounds 679
US8106073B2 (en)	2007-11-30	2012-01-31	Astrazeneca Ab	Quinoline derivatives 057

Also Published As

Publication number	Publication date
BR6460975D0 (pt)	1973-08-09
SE320363B (fr)	1970-02-09
NL6408505A (fr)	1965-01-25
DE1793207A1 (de)	1972-03-30
DK114199B (da)	1969-06-09
DK112027B (da)	1968-11-04
IL21753A (en)	1968-01-25
FR1572956A (fr)	1969-07-04
ES302369A1 (es)	1965-03-16
SE330693B (fr)	1970-11-30
US3352912A (en)	1967-11-14
DE1792295B1 (de)	1971-05-27
DE1793208A1 (de)	1972-04-06
FI42548B (fr)	1970-06-01
FI42322B (fr)	1970-03-31
SE321924B (fr)	1970-03-23
DE1468769B1 (de)	1972-06-29
FI42211B (fr)	1970-03-02
DK114769B (da)	1969-08-04
CH479535A (de)	1969-10-15
NL7102097A (fr)	1971-05-25
AT279581B (de)	1970-03-10
CH476673A (de)	1969-08-15
GB1069563A (en)	1967-05-17

Publication	Publication Date	Title
FI42211B (fr)	1970-03-02
AT260747B (fr)	1968-03-25
BE627012A (fr)
BE627025A (fr)
BE626986A (fr)
BE547422A (fr)
BE533484A (fr)
BE507458A (fr)
BE465565A (fr)
BE627145A (fr)
BE571209A (fr)
BE582314A (fr)
BE612803A (fr)
BE462764A (fr)
BE31062A (fr)
BE645040A (fr)	1964-09-11
BE627083A (fr)
BE624070A (fr)
BE627023A (fr)
BE603935A (fr)
BE627141A (fr)
BE626938A (fr)
BE645860A (fr)	1964-07-16
BE645831A (fr)	1964-09-28
BE624811A (fr)